Aberrant IL-6 signaling upregulates expression of SENP1 at least partly through the induction of the JAK-STAT-signaling pathway, and the treatment of MM cells with JAK-STAT inhibitor AG490 diminishes IL-6-mediated upregulation of SENP1 [195]. Here, SOAT1 is linked to Miyoshi myopathy.